MedTrace Logo

18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.

NCT06164561 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2026-02-04

No results posted yet for this study

Summary

This study intends to use a prospective, observational, self-controlled, multi-center study design to evaluate the feasibility and diagnostic efficacy of 18F-FDG PET/CT and 18F-FAPI PET/MRI imaging for the evaluation of systemic fibrosis in MF patients based on the results of bone marrow pathological biopsy, and to analyze the relationship between imaging results and clinical prognosis.

Conditions

Sponsors & Collaborators

  • Zhejiang Provincial Tongde Hospital

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator OTHER

  • Zhejiang Cancer Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Zhejiang Chinese Medical University

    collaborator OTHER

  • First People's Hospital of Hangzhou

    collaborator OTHER

  • Sir Run Run Shaw Hospital

    collaborator OTHER

  • First Affiliated Hospital of Zhejiang University

    lead OTHER

Principal Investigators

  • Jie Sun, MD，Ph.D · Zhejiang University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-21
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06164561 on ClinicalTrials.gov